Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/33983
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorNYITRAY, Alan G.-
dc.contributor.authorPENG, Fen-
dc.contributor.authorDAY, Rena S.-
dc.contributor.authorSILVA, Roberto J. Carvalho Da-
dc.contributor.authorBAGGIO, Maria Luiza-
dc.contributor.authorSALMERON, Jorge-
dc.contributor.authorQUITERIO, Manuel-
dc.contributor.authorABRAHAMSEN, Martha-
dc.contributor.authorLAZCANO-PONCE, Eduardo-
dc.contributor.authorVILLA, Luisa L.-
dc.contributor.authorGIULIANO, Anna R.-
dc.date.accessioned2019-11-06T18:46:41Z-
dc.date.available2019-11-06T18:46:41Z-
dc.date.issued2019-
dc.identifier.citationHUMAN VACCINES & IMMUNOTHERAPEUTICS, v.15, n.7-8, Special Issue, p.1911-1919, 2019-
dc.identifier.issn2164-5515-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/33983-
dc.description.abstractBackground: While receptive anal sex is an established risk factor for anal human papillomavirus (HPV) infection and squamous cell carcinoma of the anus (SCCA), people with anal HPV infection and SCCA commonly report no lifetime receptive anal sex suggesting other factors may also increase risk for anal HPV infection and persistence. Given potential associations between obesity and conditions that may cause perianal or anal canal lesions, we hypothesized that body mass index (BMI) was associated with HPV infection.Methods: Genotyping for 36 HPV types was conducted on anal canal specimens from men, ages 18-70, from Brazil, Mexico, and the USA. Eligibility included no history of genital warts or HIV. Evaluable specimens were collected from 328 men having sex with men (MSM) and 1348 men having sex with women (MSW) who reported no lifetime receptive anal sex. Prevalence of anal HPV infection and six-month persistence by BMI were estimated in addition to adjusted prevalence ratios for the association between BMI and HPV infection.Results: Among MSW, obese men had a higher prevalence of HPV-16 in the anal canal (3.1%), compared to normal weight men (1.3%) although 95% CI overlapped. Among MSM, prevalence of HPV decreased with increasing BMI. A similar pattern was observed for persistence. After adjustment for confounders, obese MSW had 2.4 times higher odds of HPV-16 compared to normal weight men.Conclusions: BMI may be positively associated with anal HPV (especially HPV-16) among MSW and negatively associated with anal HPV among MSM which supports continued universal HPV vaccination programs.eng
dc.description.sponsorshipNational Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [5R21AI101417-3]-
dc.description.sponsorshipNational Cancer Institute (NCI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [NIH RO1 CA098803 01-A1]-
dc.language.isoeng-
dc.publisherTAYLOR & FRANCIS INCeng
dc.relation.ispartofHuman Vaccines & Immunotherapeutics-
dc.rightsrestrictedAccesseng
dc.subjectHPVeng
dc.subjectmeneng
dc.subjectpersistenceeng
dc.subjectepidemiologyeng
dc.subjectBMIeng
dc.subjectheterosexual meneng
dc.subject.otherinflammatory-bowel-diseaseeng
dc.subject.otherrisk-factorseng
dc.subject.othersexual practiceseng
dc.subject.othercancereng
dc.subject.otherinfectioneng
dc.subject.othermeneng
dc.subject.otherhpveng
dc.subject.otherhealtheng
dc.subject.othertrendseng
dc.subject.otherwomeneng
dc.titleThe association between body mass index and anal canal human papillomavirus prevalence and persistence: the HIM studyeng
dc.typearticleeng
dc.rights.holderCopyright TAYLOR & FRANCIS INCeng
dc.identifier.doi10.1080/21645515.2019.1593083-
dc.identifier.pmid30897017-
dc.subject.wosBiotechnology & Applied Microbiologyeng
dc.subject.wosImmunologyeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalNYITRAY, Alan G.:Med Coll Wisconsin, Ctr Clin Canc, 2071 North Summit Ave, Milwaukee, WI 53202 USA; Med Coll Wisconsin, Ctr AIDS Intervent Res, 2071 North Summit Ave, Milwaukee, WI 53202 USA-
hcfmusp.author.externalPENG, Fen:Medtronic Inc, Dept Clin Res, Northridge, CA USA-
hcfmusp.author.externalDAY, Rena S.:Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA-
hcfmusp.author.externalSILVA, Roberto J. Carvalho Da:Ctr Referencia & Treinamento DST AIDS, Dept STDs, Sao Paulo, Brazil-
hcfmusp.author.externalSALMERON, Jorge:Univ Nacl Autonoma Mexico, Rese Ctr Policies Populat & Hlth, Fac Med, Mexico City, DF, Mexico; Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico-
hcfmusp.author.externalQUITERIO, Manuel:Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico-
hcfmusp.author.externalABRAHAMSEN, Martha:H Lee Moffitt Canc Ctr & Res Inst, Ctr Immunizat & Infect Res Canc, Tampa, FL USA-
hcfmusp.author.externalLAZCANO-PONCE, Eduardo:Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico-
hcfmusp.author.externalGIULIANO, Anna R.:H Lee Moffitt Canc Ctr & Res Inst, Ctr Immunizat & Infect Res Canc, Tampa, FL USA-
hcfmusp.description.beginpage1911-
hcfmusp.description.endpage1919-
hcfmusp.description.issue7-8-
hcfmusp.description.issueSpecial Issue-
hcfmusp.description.volume15-
hcfmusp.origemWOS-
hcfmusp.origem.idWOS:000482271400060-
hcfmusp.origem.id2-s2.0-85064652852-
hcfmusp.publisher.cityPHILADELPHIAeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceBARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173eng
hcfmusp.relation.referenceBeaugerie L, 2018, CLIN GASTROENTEROL H, V16, P892, DOI 10.1016/j.cgh.2017.11.041eng
hcfmusp.relation.referenceBeck D, 2009, ASCRS MANUAL COLON R, P259eng
hcfmusp.relation.referenceBouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8eng
hcfmusp.relation.referenceCenters for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1705eng
hcfmusp.relation.referenceChaturvedi AK, 2010, J ADOLESCENT HEALTH, V46, pS20, DOI 10.1016/j.jadohealth.2010.01.016eng
hcfmusp.relation.referenceChiao EY, 2005, JAIDS-J ACQ IMM DEF, V40, P451, DOI 10.1097/01.qai.0000159669.80207.12eng
hcfmusp.relation.referenceChutkan R, 2012, J AM ACAD NURSE PRAC, V24, P476, DOI 10.1111/j.1745-7599.2012.00758.xeng
hcfmusp.relation.referenceCress RD, 2003, PREV MED, V36, P555, DOI 10.1016/S0091-7435(03)00013-6eng
hcfmusp.relation.referenceDaling JR, 2004, CANCER, V101, P270, DOI 10.1002/cncr.20365eng
hcfmusp.relation.referenceDALING JR, 1987, NEW ENGL J MED, V317, P973, DOI 10.1056/NEJM198710153171601eng
hcfmusp.relation.referenceDoorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083eng
hcfmusp.relation.referenceFrisch M, 1998, BRIT J CANCER, V78, P1534, DOI 10.1038/bjc.1998.719eng
hcfmusp.relation.referenceFrisch M, 1997, NEW ENGL J MED, V337, P1350, DOI 10.1056/NEJM199711063371904eng
hcfmusp.relation.referenceGarland SM, 2016, CLIN INFECT DIS, V63, P519, DOI 10.1093/cid/ciw354eng
hcfmusp.relation.referenceGiuliano AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151eng
hcfmusp.relation.referenceGiuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2eng
hcfmusp.relation.referenceGravitt PE, 1998, J CLIN MICROBIOL, V36, P3020eng
hcfmusp.relation.referenceGravitt PE, 2000, J CLIN MICROBIOL, V38, P357eng
hcfmusp.relation.referenceHalperin DT, 1999, AIDS PATIENT CARE ST, V13, P717, DOI 10.1089/apc.1999.13.717eng
hcfmusp.relation.referenceHanauer SB, 2001, AM J GASTROENTEROL, V96, P635eng
hcfmusp.relation.referenceHernandez BY, 2005, CANCER EPIDEM BIOMAR, V14, P2550, DOI 10.1158/1055-9965.EPI-05-0460eng
hcfmusp.relation.referenceHOLLY EA, 1989, JNCI-J NATL CANCER I, V81, P1726, DOI 10.1093/jnci/81.22.1726eng
hcfmusp.relation.referenceHOLMES F, 1988, GASTROENTEROLOGY, V95, P107, DOI 10.1016/0016-5085(88)90297-1eng
hcfmusp.relation.referenceIslami F, 2017, INT J EPIDEMIOL, V46, P924, DOI 10.1093/ije/dyw276eng
hcfmusp.relation.referenceJENSEN SL, 1988, DIS COLON RECTUM, V31, P770, DOI 10.1007/BF02560104eng
hcfmusp.relation.referenceKreuter R, 2019, BBA-MOL BASIS DIS, V1865, P63, DOI 10.1016/j.bbadis.2018.10.020eng
hcfmusp.relation.referenceLin CQ, 2018, LANCET INFECT DIS, V18, P198, DOI [10.1016/s1473-3099(17)30653-9, 10.1016/S1473-3099(17)30653-9]eng
hcfmusp.relation.referenceLiu G, 2015, SEX TRANSM DIS, V42, P20, DOI 10.1097/OLQ.0000000000000231eng
hcfmusp.relation.referenceMadalinski Mariusz H, 2011, World J Gastrointest Pharmacol Ther, V2, P9, DOI 10.4292/wjgpt.v2.i2.9eng
hcfmusp.relation.referenceMarkland AD, 2013, AM J GASTROENTEROL, V108, P796, DOI 10.1038/ajg.2013.73eng
hcfmusp.relation.referenceNyitray A, 2008, J INFECT DIS, V197, P1676, DOI 10.1086/588145eng
hcfmusp.relation.referenceNyitray AG, 2016, CLIN INFECT DIS, V62, P1367, DOI 10.1093/cid/ciw140eng
hcfmusp.relation.referenceNyitray AG, 2011, J INFECT DIS, V204, P1711, DOI 10.1093/infdis/jir637eng
hcfmusp.relation.referenceNyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021eng
hcfmusp.relation.referenceNyitray AG, 2010, J INFECT DIS, V201, P1498, DOI 10.1086/652187eng
hcfmusp.relation.referenceNyitray AG, 2009, AM J EPIDEMIOL, V170, P965, DOI 10.1093/aje/kwp225eng
hcfmusp.relation.referencePetrosky E, 2015, MMWR-MORBID MORTAL W, V64, P300eng
hcfmusp.relation.referencePiketty C, 2003, ANN INTERN MED, V138, P453, DOI 10.7326/0003-4819-138-6-200303180-00008eng
hcfmusp.relation.referenceProctor Robert N, 2004, Clin Lung Cancer, V5, P371, DOI 10.3816/CLC.2004.n.016eng
hcfmusp.relation.referenceQuan S, 2011, GASTROENTEROLOGY, V140, pS730eng
hcfmusp.relation.referenceRoberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598eng
hcfmusp.relation.referenceRothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87eng
hcfmusp.relation.referenceRuel J, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.8eng
hcfmusp.relation.referenceSavin-Williams RC, 2007, ARCH SEX BEHAV, V36, P385, DOI 10.1007/s10508-006-9088-5eng
hcfmusp.relation.referenceSchiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108eng
hcfmusp.relation.referenceShah SB, 2015, CLIN GASTROENTEROL H, V13, P1955, DOI 10.1016/j.cgh.2015.05.031eng
hcfmusp.relation.referenceSlesser AAP, 2013, SURG ONCOL, V22, P230, DOI 10.1016/j.suronc.2013.08.002eng
hcfmusp.relation.referenceSteele SR, 2006, ALIMENT PHARM THERAP, V24, P247, DOI 10.1111/j.1365-2036.2006.02990.xeng
hcfmusp.relation.referenceTseng HF, 2003, CANCER CAUSE CONTROL, V14, P837, DOI 10.1023/B:CACO.0000003837.10664.7feng
hcfmusp.relation.referencevan der Zee RP, 2013, NETH J MED, V71, P401eng
hcfmusp.relation.referenceVuitton L, 2018, CLIN GASTROENTEROL H, V16, P1768, DOI 10.1016/j.cgh.2018.03.008eng
hcfmusp.relation.referenceWeinhardt LS, 1998, ARCH SEX BEHAV, V27, P155, DOI 10.1023/A:1018682530519eng
hcfmusp.relation.referenceWisniewski A, 2017, J CROHNS COLITIS, V11, P1011, DOI 10.1093/ecco-jcc/jjx035eng
dc.description.indexMEDLINEeng
dc.identifier.eissn2164-554X-
hcfmusp.citation.scopus7-
hcfmusp.scopus.lastupdate2024-03-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MDR
Departamento de Radiologia - FM/MDR

Artigos e Materiais de Revistas Científicas - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Artigos e Materiais de Revistas Científicas - LIM/24
LIM/24 - Laboratório de Oncologia Experimental

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_NYITRAY_The_association_between_body_mass_index_and_anal_2019.PDF
  Restricted Access
publishedVersion (English)1.31 MBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.